Maternal Dehydro-Epiandrosterone Sulfate Serum Level and Bishop Score in Prolonged Pregnancy

Research Article

Austin J Obstet Gynecol. 2019; 6(1): 1135.

Maternal Dehydro-Epiandrosterone Sulfate Serum Level and Bishop Score in Prolonged Pregnancy

Gharib WF*

¹Department of Obstetrics and Gynecology, Suez Canal University, Egypt

*Corresponding author: Waleed Fouad Gharib, Department of Obstetrics and Gynecology, Faculty of Medicine, Suez Canal University, Round Road, Ismailia 41111, Egypt

Received: February 27, 2019; Accepted: April 01, 2019; Published: April 08, 2019

Abstract

Objective: To test the relation between pre-induction maternal serum level of dehydro-epiandrosterone sulfate and Bishop score in prolonged pregnancy.

Design: Observational prospective cohort study.

Setting: Department of Obstetrics and Gynecology, Suez Canal University Hospitals, Ismailia, Egypt.

Population: 40 pregnant women with singleton normal pregnancies at gestational age 40-42 weeks were recruited in the study.

Methods: Data collection included taking a thorough medical history, with emphasis on a detailed obstetric history, doing a complete physical examination. Vaginal examination was done and Bishop Score was recorded. Before initiation of induction a venous blood sample for DHEA-S level assay by ELISA technique.

Results: There was a highly significant positive correlation between DHEAS serum level and the Bishop score as higher DHEAS levels are associated with higher Bishop Scores (r=0.32; p‹0.05). The mean DHEA-S among those with favorable cervix was much higher than those with unfavorable cervix (92.68±46.88 vs. 64.62±26.27 with significant p value =0.03)

Conclusion: pre-induction serum DHEA-S correlates positively with Bishop Score and there is possibility to use it as alternative objective option to help anticipation of successful induction of labor in prolonged pregnancy.

Keywords: Dehydroepiandrosterone sulfate (DHEA-S); Prolonged pregnancy; Bishop Score

Introduction

Post term pregnancy occurs in 3 to 13% of pregnancies; prolonged pregnancy is associated with significant risks to the pregnant woman, including perineal injury due to fetal macrosomia, high rate of cesarean delivery and labor dystocia. It may be also associated with considerable risks to the fetus such as increased perinatal mortality rate, increased risk of umbilical cord compression from oligohydramnios, low 5-minute Apgar scores, and meconium aspiration [1].

Some studies have shown a reduction in neonatal mortality by routine labor induction at 41st week of gestation. Management of cases of prolonged pregnancy remains a tough situation for the obstetricians [2].

Dehydroepiandrosterone Sulfate (DHEA-S) is a weak androgenic steroid produced by the adrenal cortex of the pregnant female. After birth, output drops to negligible amounts in both sexes, and remains that way until seven years of age. Later on, the adrenal glands gradually resume DHEA and DHEAS production, which accelerates through puberty. DHEA and DHEAS output is maximal between the second third decades and then starts a decline of approximately 2% per year leaving only a residual of 10-20% of the peak production by the eighth of ninth decade of life [3].

Both of them serve as the precursors of approximately 50% of androgens in men, 75% of active estrogens in premenopausal women, and 100% of active estrogens after menopause [3].

Many studies have done about DHEA-S to understand its role in the pregnant female. It is found that the serum levels of DHEA-S are significantly lower in those requiring pharmacologic intervention than in those progressing spontaneously [4].

Receptors for DHEA-S have been identified on the plasma membranes of human cervical fibroblasts suggesting that this hormone may play a role in cervical connective tissue function [5]. There is also sufficient evidence that DHEA-S has a direct action on uterine collagenase activation [6].

DHEA-S with the previously mentioned relation to cervical connective tissue function and direct action on uterine collagenase is expected to correlate well with the cervical connective tissue changes and consequently Bishop Score.

The aim of this study was to test the effects of DHEA-S on cervical connective tissue and consequently to test the presence of a correlation with Bishop Score.

Patients and Methods

Patients

This is an observational prospective cohort study which was performed at the department of Obstetrics and Gynecology, ward of Obstetric emergencies, Suez Canal University hospital. It was designed to study the relationship between pre-induction DHEAS levels and Bishop score in pregnant females with prolonged pregnancies ongoing induction of labor. A total of 40 pregnant women with singlton pregnancies, vertex presentation, sure date at gestational age 40-42 weeks were recruited in the study. Those with fetal congenital anomalies, twin pregnancy, malpresentations, maternal medical diseases like diabetes, abnormally implanted placenta, and obstetric disorders like preeclampsia were excluded from the study.

Methods

After obtaining informed consent all the patients in the study were subjected to Full detailed history, General examination including vital data, Abdominal examination (including fundal level. umbilial grib, and pelvic gribs), per vaginal examination to assess Bishop score.

DHEAS measurement

Before termination of pregnancy, five [5] milliliters of venous blood was taken into plain tubes from all these patients and centrifuged immediately; serum stored at -7ºC to be analyzed. Collected samples were tested for DHEA-S level by ELISA technique (Diagnostic Products Corporation [DPC], Los Angeles, CA, USA), Serum level of DHEAS was measured using ELISA (Stat Fax®2100- Awareness Technology), the Coat-A-Count DHEA-S is designed for quantitative measurement of DHEA-S in plasma and serum. The test can detect as little as 1.1μg/dl of DHEA-S.

In the Coat-A-Count DHEAS procedure, 125I-labeled DHEAS competes with DHEAS in the patient sample for sites on antibody coated tubes. After incubation, separation of the bound from free is achieved simply decanting. The tube is then counted in a gamma counter, the count being inversely related the amount of DHEAS present in the patient sample. The quantity of DHEAS in the sample is determined by comparing the counts to a calibration curve. The reagent should be incubated for 30 minutes. The test can detect as little as 1.1μg/dl.

Outcome

Assessment of the relationship between pre- induction Maternal serum level of DHEAS and Bishop score.

Statistical analysis

Descriptive statistics for measured variables were expressed as range, mean and standard deviation (for metric data); and number and proportions (for categorical data).

The gestational age among the studied group ranged from 281 to 292 day with mean 284.62 day. Regarding bishop score it ranged from 2 to 9 with mean 5.65 (Table 1).